BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PANAMA

被引：0
|
作者：
Torres Toala, F. G. [1 ]
Solorzano, J. [2 ]
Baldi, J. [2 ]
Castillo-Fernandez, O. [3 ]
机构：
[1] Makroscopio, Quito, Ecuador
[2] AstraZeneca CAMCAR MAC, San Jose, Costa Rica
[3] Inst Oncol Nacl, Panama City, Panama
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN56
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN PERU
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    VALUE IN HEALTH, 2018, 21 : S22 - S22
  • [2] BUDGET IMPACT ANALYSIS FOR OLAPARIB MAINTENANCE THERAPY FOR BRCA-MUTATED PLATINUM SENSITIVE RECURRENT OVARIAN CANCER IN COSTA RICA
    Torres Toala, F. G.
    Solorzano, J.
    Baldi, J.
    Landaverde, D.
    Gonzalez, I
    VALUE IN HEALTH, 2018, 21 : S21 - S21
  • [3] Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer
    Angela Cho
    Jeong-Yeol Park
    Shin-Wha Lee
    Dae-Yeon Kim
    Dae-Shik Suh
    Jong-Hyeok Kim
    Yong-Man Kim
    Young-Tak Kim
    Archives of Gynecology and Obstetrics, 2021, 304 : 1055 - 1063
  • [4] Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer
    Cho, Angela
    Park, Jeong-Yeol
    Lee, Shin-Wha
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1055 - 1063
  • [5] Overview: FDA Approval of Olaparib Maintenance for BRCA-Mutated Ovarian Cancer
    Saleh, Naveed
    Copur, Mehmet Sitki
    ONCOLOGY-NEW YORK, 2019, 33 (07): : 293 - 294
  • [6] Olaparib for BRCA-mutated advanced ovarian cancer
    de Lartigue, Jane
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (06): : 206 - 208
  • [7] Olaparib for the treatment of BRCA-mutated advanced ovarian cancer
    Munroe, Marklie
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (14) : 1037 - 1041
  • [8] Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Golan, Talia
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Park, Joon-Oh
    Hochhauser, Daniel
    Arnold, Dirk
    Oh, Do-Youn
    Reinacher-Schick, Anke
    Tortora, Giampaolo
    Alguel, Hana
    O'Reilly, Eileen M.
    McGuinness, David
    Cui, Karen Y.
    Schlienger, Katia
    Locker, Gershon Y.
    Kindler, Hedy L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04): : 317 - 327
  • [9] Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US
    Wu, Lei
    Zhong, Lixian
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 187 - 195
  • [10] EFFICACY AND SAFETY OF MAINTENANCE OLAPARIB BY PATIENT AGE IN NON-GERMLINE BRCA-MUTATED PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER IN OPINION
    Skof, E.
    Bjurberg, M.
    Rubio Perez, M. J.
    Davidson, D.
    Blakeley, C.
    Bennett, J.
    Poveda, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A202 - A203
12345